We are launching a quarterly newsletter to share our progress across key initiatives and where we are headed next. Each edition brings highlights from the past quarter and a preview of what is coming.
Subscribe via our website to follow along!
Ossiform® obtains #ISO13485 certification📜
Obtaining the certification is an important milestone, demonstrating Ossiform’s dedication to ensuring the highest quality and safety standards in the design, production, and provision of its bone implants.
Read more on our website
In this app note, we present how Ossi Ink provides a suitable substrate for bone tissue, both in vitro and in vivo, and represents a valuable alternative to current surgical solutions that could, in the future, be applied at the patient’s bedside. https://t.co/NFlQ8Zm17f
We are headed towards LSI USA '24!
Our CEO and Sales & Marketing Manager will be representing Ossiform at the world-class conference, Emerging #MedTech Summit.
We are looking forward to engage, connect and be inspired, and we hope to see you there!
#WePrintBone#LSIUSA24
Ossiform (#LSIUSA24 Innovator) is dedicated to improving the lives of people with bone defects.
The company provides patient specific, natural, and resorbable bone implants to reduce complications, improve functional and aesthetic outcomes and obtain faster recovery.
Our CTO, Martin Bonde Jensen, is representing Ossiform at the #bioprinting event of the year!
From October 25-27, key opinion leaders, #lifescience experts, and bioprinting specialists are gathering for this year’s @CELLINK3D Partnership Conference.
Registration is still open✅
We have partnered up with @MaterialiseNV who provides an all-in-one #software that eases our patient specific implant creation process. You can read more about why we chose Materialise as our software partner in this article ⬇️
#WePrintBone#3Dprinting
https://t.co/1uTdy2ud1V
How do #3Dprinting bones and #3Dscanning go hand in hand?🤝
Learn more about why we use this method in this new blog post from @HMetrology !
https://t.co/51RhcMcEsA
@formnext_expo recently interviewed Ossiform's CTO, Martin Bonde Jensen, where he shared his story about how he got involved in the 3D printing technology of bone graft substitutes, and how the company has developed since then 🚀
Read the article here:
https://t.co/1wVU8P0xqi
We are thrilled to announce that @akita_bio has published a whitepaper in partnership with @Ossiform_com.
For more in-depth insights and access to application note, visit https://t.co/a56JbvKQEf
We’re proud to have become a member of @NA3RsC Microphysiological Systems (MPS) initiative as a provider of commercially available microphysiological system technology, having a core mission focused on microphysiological systems.
Learn more: https://t.co/8tI69A1cfM
See you this week in Düsseldorf at #MEDICA2022 - the world’s largest event for the medical sector🏥
@Ossiform_com is at the Pavilion of Denmark together with 28 other Danish companies to showcase our bone printing technology.
Düsseldorf - where healthcare is going 🚑
Next week, we are heading to New Orleans for the annual meeting of The American Association of Oral and Maxillofacial Surgeons.
A part of @Ossiform_com team will be in attendance at the annual conference. Hopefully we'll see you there!
#AAOMS#AAOMS2022
We are proud to say that a 𝐧𝐞𝐰 𝐩𝐚𝐭𝐞𝐧𝐭 has been granted to Ossiform in Mexico💡
This marks our 𝐟𝐢𝐟𝐭𝐡 patent insurance together with USA, Europe, Japan and China, all lined up on our motivation wall we all walk by every day 🧾🙌
#WePrintBone#3dprinting#lifescience
Ossiform and CAM Bioceramics team up for #OMTEC 2022
This time we are headed to Chicago, USA where we will be a part of The Orthopaedic Manufacturing & Technology Exposition and Conference, which will take place June 14-16.
Read the announcement here: https://t.co/n7FZxOIiSL
Over 𝟮𝟬𝟬 implants for packaging tests have now been completed by our incredible Production and Quality Assurance team! ✅
These tests are an important part of the regulatory process toward FDA approval of Ossiform's first P3D Bone implant.
#WePrintBone#3dprinting#medtech